Last weekend, Evinova’s General Manager of China, Nate Zhang, delivered an inspiring keynote at #DIAChina2025 in Shanghai. During his talk, Nate shared Evinova's story and how we are leveraging AI advancements to revolutionize clinical research. Highlights from the presentation: The challenges faced by the clinical research sector Evinova’s innovative, data-driven and AI-powered solutions that are accelerating clinical studies globally, including in China. Powerful case studies demonstrating the measurable value Evinova has delivered for sponsors, sites and patients across numerous clinical trials. With our cutting-edge digital health solutions underpinned by our AI-enabled platform, were making clinical trials more efficient, effective, and patient-friendly. This is just the beginning for the growing Evinova China team. Missed us at DIA China? 📩 Contact us at BDChina@evinova.com to explore how Evinova can accelerate your clinical studies. #ClinicalTrials #PatientCentric #Innovation #DigitalHealth #ClinicalResearch #DCT
About us
Digital solutions need to do more to propel clinical development, elevate user experiences and accelerate better health outcomes. At Evinova, we’re doing something about it. We’re a healthtech business, with globally-scaled digital products that have proven benefits for sponsors, sites and patients. We've accelerated timelines, improved patient experiences, reduced costs, and minimised carbon footprints across hundreds of clinical studies. Evinova is a 300+ person strong team offering digital solutions to pharma, biotech and CROs to support clinical research globally. Community Guidelines: http://bit.ly/3JIeErQ
- Website
-
https://evinova.com/
External link for Evinova
- Industry
- Software Development
- Company size
- 201-500 employees
- Type
- Public Company
- Founded
- 2023
- Specialties
- Pharmaceutical, Biopharmaceutical, Innovation, Technology solutions, Global business, and Healthtech
Employees at Evinova
-
Simon Pulman-Jones
Head of Design, Patient Solutions @ Evinova, an AstraZeneca Healthtech Business
-
Niklas Antoncic
Callista Enterprise AB
-
Christel Minning
Senior Business Analyst and Consultant Manager at Omegapoint
-
Elisa C.
Associate Director, Clinical Outcomes Assessment at Evinova, an AstraZeneca Healthtech Business
Updates
-
This year has marked a significant shift in the life sciences industry, with many companies rapidly embracing digital technologies and AI to accelerate clinical development and deliver improved patient outcomes. At the intersection of cutting-edge technologies and healthcare, Evinova's Gizem Demircioglu, Director of Digital Health Strategy, will join a lineup of experts at #NYTechWeek. Alongside healthcare innovators and VCs, Gizem will discuss how artificial intelligence and digital technologies, including Evinova's AI-enabled clinical development platform, are reshaping the health and med tech landscapes today and in the future. #NYTechWeek #MedTech #clinicaltrials #digitalinnovation
-
-
With decades of experience in oncology research, our experts design fit-for-purpose digital solutions and strategies to optimize trial success. From reducing patient burden to delivering real-time insights, we help sponsors collect the right data to support the best outcomes. 📍 Connect with us at #ASCO25 or visit our website to discover how we can partner to drive innovation in cancer research. 👉 Learn more here ➡️ https://lnkd.in/edFE2sk4 #Innovation #OncologyResearch #ClinicalTrials
-
-
Cancer research brings big opportunities—but also unique challenges. At Evinova, we empower clinical teams with purpose-built digital solutions tailored for the complexities of oncology trials. Heading to ASCO this year? Connect with our team to learn how Evinova’s data-driven solutions can help with: · Real-time toxicity monitoring for improved outcomes · Simplifying trial participation for sites and patients · Accelerating breakthroughs with AI-powered study design and planning We are proud to partner with oncology leaders worldwide. Explore our oncology solutions: https://lnkd.in/edFE2sk4 #ASCO2025 #OncologyExperts #DigitalHealth Cristina Ortega Duran, Diane Lewis, Shawn Tedman, James Thatcher, Camila Matheny
-
-
Did you know real-time remote patient monitoring (RPM) can improve the management of treatment-related toxicities, potentially helping patients in clinical trials stay on cancer treatment longer? In this video, Cristina Ortega Duran shares the story of a patient in a clinical trial who withheld the side effects of her investigational cancer treatment from her doctor due to fear of being pulled from the study. This led to avoidable complications, including dehydration and treatment interruption. At Evinova, our fit-for-purpose RPM modules empower sites to intervene early, before high-grade toxicities develop that may lead to treatment interruption. With innovation at the forefront, we’re working with sponsors to design trials for novel modalities such as antibody-drug conjugates that minimize the burden on patients while delivering actionable real-time data to clinical teams. Interested in how our tech impacts oncology trial outcomes? Learn more: https://lnkd.in/edFE2sk4 #ASCO2025 #OncologyResearch #RemotePatientMonitoring #ClinicalInnovation Cristina Ortega Duran, Matthew Bonam, Sean Connolly
-
Meet Evinova at ASCO 2025 to discover how our proven digital solutions are improving oncology clinical trials. From AI-powered study design to actionable remote toxicity monitoring, Evinova’s clinical trial technology is helping leading oncology researchers accelerate trial delivery, improve outcomes and reduce patient burden. Connect with our team to learn how Evinova can support you in delivering the next generation of cancer therapies. 📅 May 30 - June 3, 2025 Schedule a meeting: meetings@evinova.com #ASCO2025 #OncologyInnovation #ClinicalTrials #CancerResearch
-
-
At Evinova, our work is more than a profession – it’s personal too. To commemorate International Clinical Trials Day, some of our employees share their experiences as participants and patients and the impactful lessons they carry with them in their day-to-day roles. https://lnkd.in/eu7W6FgD We’re proud to collaborate with global research leaders to enhance trial accessibility, efficiency, and patient-centricity through technology. Thank you to all researchers, participants and caregivers who play a role in driving medical innovation forward! #ClinicalTrialsDay #CTD2025 #poweredbypurpose #digitalhealth ACRP - Association of Clinical Research Professionals, Kelly McKee, Heather Bonsiero, Colby Flint
-
-
How interchangeable are digital modalities in capturing clinical outcomes? New Evinova research presented at #ISPOR2025 explores the usability and equivalence of smartphone and web-based eCOA formats. Results show strong consistency across modalities for most response scales, indicating that web-based formats can supplement smartphone applications to maximize inclusivity and compliance. Unified Trial Solution, Evinova’s all-in-one trial management platform offers both app and web-based log in for participants, with modular features configured to suit your study needs. Learn more here: https://evinova.com/uts #DigitalHealth #eCOA #ClinicalOutcomes #PatientCentricity ISPOR—The Professional Society for Health Economics and Outcomes Research; Indira Jain-Figueroa, Shannon Kummer, Anna Kündig
-
-
Are sensors the future of clinical measurement - or just one piece of the puzzle? At ISPOR 2025, our Head of Endpoints, Libby Floden, joins a leading panel to explore where sensor-based data shines, why patient-reported outcomes remain essential and how to align both with meaningful health endpoints. Where: Montreal, Canada When: 14 May 2025 Explore the full ISPOR 2025 program: https://lnkd.in/evUTWNse #ISPOR2025 #DigitalHealth #ClinicalOutcomes #PatientCentricity ISPOR—The Professional Society for Health Economics and Outcomes Research
-
-
📰 ICYMI: Evinova’s Unified Trial Solution featured on TV Asahi news! According to the story, 143 newly approved medicines in Europe and the US are not accessible to patients in Japan, an issue known as “drug loss.” There are several initiatives underway to accelerate and promote clinical trials in Japan to address this problem. Unified Trial Solution our single, fully integrated app, is highlighted as one way to make it easier for patients in Japan to participate in clinical trials. In the study featured, nine of twelve study visits can be conducted remotely through the app and medication is delivered directly to the patients’ homes. Data collected from patients at home is sent to sites for follow up in the case of abnormal symptoms that require further intervention. Watch the full story here on the TV Asahi archives : https://lnkd.in/ei_cVjKN This is one of many studies using Unified Trial Solution to improve the trial experience for sponsors, sites and patients! Learn more about our proven solution here: https://evinova.com/uts #clinicaltrials #dct #clinicaltrialtech
-